(Q46627810)

English

Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications

scientific article published in June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

author name string

J Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

E Alemao

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

D Yin

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

J Cook

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

10 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

33-42

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

The burden of treatment failure in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Clinical inertia contributes to poor diabetes control in a primary care setting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Clinical inertia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Guidelines for computer modeling of diabetes and its complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Insulin glargine and educational intervention in patients with type 2 diabetes in clinical practice: long-term improvement in glycaemic control without weight gain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00885.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2008.00885.X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18435672

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46627810&oldid=2123054663"